Primary immunodeficiency diseases: an update on the classification from the International Union of Immunological Societies Expert Committee for primary immunodeficiency, Front Immunol, vol.5, p.162, 2014. ,
ESCMID* guideline for the diagnosis and management of Candida diseases 2012: adults with haematological malignancies and after haematopoietic stem cell transplantation (HCT), Clin Microbiol Infect, vol.18, issue.7, pp.53-67, 2012. ,
Genetic, biochemical, and clinical features of chronic granulomatous disease, vol.79, pp.170-200, 2000. ,
Invasive mold infections in chronic granulomatous disease: a 25-year retrospective survey, Clin Infect Dis, vol.53, pp.159-69, 2011. ,
Continuous therapy with sulfamethoxazole-trimethoprim in patients with chronic granulomatous disease, J Pediatr, vol.103, pp.127-157, 1983. ,
Trimethoprimsulfamethoxazole prophylaxis in the management of chronic granulomatous disease, J Infect Dis, vol.162, pp.723-729, 1990. ,
Incidence, severity, and prevention of infections in chronic granulomatous disease, J Pediatr, vol.114, pp.555-60, 1989. ,
Itraconazole to prevent fungal infections in chronic granulomatous disease, N Engl J Med, vol.348, pp.2416-2438, 2003. ,
, A controlled trial of interferon gamma to prevent infection in chronic granulomatous disease. The International Chronic Granulomatous Disease Cooperative Study Group, N Engl J Med, vol.324, pp.509-525, 1991.
Interferon gamma for chronic granulomatous disease, N Engl J Med, vol.325, pp.1516-1523, 1991. ,
Chronic granulomatous disease: the European experience, PLoS One, vol.4, p.5234, 2009. ,
URL : https://hal.archives-ouvertes.fr/hal-00382226
, Medical Advisory Committee of the Immune Deficiency Foundation
Recommendations for live viral and bacterial vaccines in immunodeficient patients and their close contacts, J Allergy Clin Immunol, vol.133, pp.961-967, 2014. ,
Congenital neutropenia: diagnosis, molecular bases and patient management, Orphanet J Rare Dis, vol.6, p.26, 2011. ,
A randomized controlled phase III trial of recombinant human granulocyte colony-stimulating factor (filgrastim) for treatment of severe chronic neutropenia, Blood, vol.81, pp.2496-502, 1993. ,
Infections of people with complement deficiencies and patients who have undergone splenectomy, Clin Microbiol Rev, vol.23, pp.740-80, 2010. ,
Primary immunodeficiencies associated with pneumococcal disease, Curr Opin Allergy Clin Immunol, vol.3, pp.451-460, 2003. ,
Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine, N Engl J Med, vol.348, pp.1737-1783, 2003. ,
Immunogenicity and safety of an investigational multicomponent, recombinant, meningococcal serogroup B vaccine (4CMenB) administered concomitantly with routine infant and child vaccinations: results of two randomised trials, Lancet, vol.381, pp.825-860, 2013. ,
Pneumococcal and influenza immunization in asplenic persons: a retrospective population-based cohort study, BMC Infect Dis, vol.10, p.219, 1990. ,
Prophylaxis with oral penicillin in children with sickle cell anemia. A randomized trial, N Engl J Med, vol.314, pp.1593-1602, 1986. ,
Pathogenesis, diagnosis, and management of primary antibody deficiencies and infections, Clin Microbiol Rev, vol.22, pp.396-414, 2009. ,
Enteroviral infections in primary immunodeficiency (PID): a survey of morbidity and mortality, J Infect, vol.46, pp.1-8, 2003. ,
The comparison of the efficacy and safety of intravenous versus subcutaneous immunoglobulin replacement therapy, J Clin Immunol, vol.20, pp.94-100, 2000. ,
Effectiveness of immunoglobulin replacement therapy on clinical outcome in patients with primary antibody deficiencies: results from a multicenter prospective cohort study, J Clin Immunol, vol.31, pp.315-337, 2011. ,
Impact of trough IgG on pneumonia incidence in primary immunodeficiency: a metaanalysis of clinical studies, Clin Immunol, vol.137, pp.21-30, 2010. ,
Efficacy of trimethoprim-sulfamethoxazole for the prevention of bacterial infections in a randomized prophylaxis trial of patients with advanced HIV infection, AIDS Res Hum Retroviruses, vol.18, pp.89-94, 2002. ,
Azithromycin for prevention of exacerbations of COPD, N Engl J Med, vol.365, pp.689-98, 2011. ,
Update in understanding common variable immunodeficiency disorders (CVIDs) and the management of patients with these conditions, Br J Haematol, vol.145, pp.709-736, 2009. ,
Late-onset combined immune deficiency: a subset of common variable immunodeficiency with severe T cell defect, Clin Infect Dis, vol.49, pp.1329-1367, 2009. ,
Infection outcomes in patients with common variable immunodeficiency disorders: relationship to immunoglobulin therapy over 22 years, J Allergy Clin Immunol, vol.125, pp.1354-60, 2010. ,
Active vaccination in patients with common variable immunodeficiency (CVID), Clin Immunol, vol.124, pp.294-303, 2007. ,
Hyper immunoglobulin M syndrome due to CD40 deficiency: clinical, molecular, and immunological features, Immunol Rev, vol.203, pp.48-66, 2005. ,
, , p.1469, 2014.
, Institut Pasteur user on, vol.22, 2020.
Hyper-immunoglobulin M syndromes caused by intrinsic B-lymphocyte defects, Immunol Rev, vol.203, pp.67-79, 2005. ,
Severe combined immunodeficiencies (SCID), Clin Exp Immunol, vol.122, pp.143-152, 2000. ,
Primary cellular immunodeficiencies, J Allergy Clin Immunol, vol.109, pp.747-57, 2002. ,
Severe combined immunodeficiency: a retrospective single-center study of clinical presentation and outcome in 117 patients, J Pediatr, vol.123, pp.564-72, 1993. ,
Human severe combined immunodeficiency: genetic, phenotypic, and functional diversity in one hundred eight infants, J Pediatr, vol.130, pp.378-87, 1997. ,
STAT3 mutations in the hyper-IgE syndrome, N Engl J Med, vol.357, pp.1608-1627, 2007. ,
The hyper-IgE syndromes, Immunol Allergy Clin North Am, vol.28, pp.277-91, 2008. ,
Autosomal dominant STAT3 deficiency and hyper-IgE syndrome: molecular, cellular, and clinical features from a French national survey, Medicine (Baltimore), vol.91, pp.1-19, 2012. ,
URL : https://hal.archives-ouvertes.fr/inserm-00717018